Stifel Financial
VIVE

Stifel Financial’s VIVEVE MED INC VIVE Stock Holding History

Stifel Financial’s Portfolio VIVE Stock Details VIVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-315
Closed -$119K – 3004
2019
Q2 		$119K Buy
+315
New +$171K ﹤0.01% 2808
2018
Q4 		– Sell
-11
Closed -$28K – 2844
2018
Q3 		$28K Buy
+11
New +$31.2K ﹤0.01% 2722

Other funds holding VIVE

HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Stifel Financial's VIVE Position: Q3 2019 in Review

Stifel Financial sold out of VIVEVE MED INC (VIVE) in Q3 2019, closing a stake of 315 shares — an estimated $119K sold.

Stifel Financial first reported a position in VIVE in Q3 2018 and held it in 2 quarters. The position peaked at $119K in Q2 2019. 11 funds tracked by Wall St. Rank hold VIVE as of Q3 2019.

  • Stifel Financial reported no remaining VIVEVE MED INC position as of Q3 2019 after selling out during the quarter.
  • Stifel Financial sold 315 VIVEVE MED INC shares in Q3 2019, an estimated $119K.
  • Stifel Financial first reported a position in VIVEVE MED INC in Q3 2018 and held it in 2 quarters.
  • Stifel Financial's VIVEVE MED INC position peaked at $119K in Q2 2019.
  • 11 funds tracked by Wall St. Rank held VIVEVE MED INC as of Q3 2019.

Based on Stifel Financial's 13F filing for Q3 2019, filed 13 Nov 2019.